Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reilly

Showing results (241-250 of 318) with videos related to

Pageof 32
Sort By:
Pediatric Blood & Cancer|September 13, 2024
Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphomaCecilia Jiang, Michele Kim, Xiaoyan Han, et al.
Circulation|February 23, 2017
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention SettingPradeep Natarajan, Robin Young, Nathan O Stitziel, et al.
Experimental Hematology & Oncology|November 22, 2014
Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trialTeresa Moran, Enriqueta Felip, Vicki Keedy, et al.
Nature Metabolism|November 20, 2021
Methionine synthase is essential for cancer cell proliferation in physiological folate environmentsMark R Sullivan, Alicia M Darnell, Montana F Reilly, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis ModelMaolin Yu, Mark W Ledeboer, Matthew Daniels, et al.
Cell Metabolism|March 26, 2019
Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are LimitingMark R Sullivan, Katherine R Mattaini, Emily A Dennstedt, et al.
Journal of the American Society of Nephrology : JASN|March 24, 2016
Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based CohortJulia Kozlitina, Haihong Zhou, Patricia N Brown, et al.
Medical Care|March 14, 2012
Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative dataBrian T Fisher, Tracey Harris, Kari Torp, et al.
Pediatric Blood & Cancer|April 10, 2026
Real-World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital-Dispensed ModelKatelyn Oranges, Kelly A Duffy, Sara McDonough, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 18, 2000
Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptideA S Dutta, M Crowther, J J Gormley, et al.
Pageof 32

Showing results (241-250 of 318) with videos related to

Sort By:
Pageof 32
Pediatric Blood & Cancer|September 13, 2024
Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphomaCecilia Jiang, Michele Kim, Xiaoyan Han, et al.
Circulation|February 23, 2017
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention SettingPradeep Natarajan, Robin Young, Nathan O Stitziel, et al.
Experimental Hematology & Oncology|November 22, 2014
Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trialTeresa Moran, Enriqueta Felip, Vicki Keedy, et al.
Nature Metabolism|November 20, 2021
Methionine synthase is essential for cancer cell proliferation in physiological folate environmentsMark R Sullivan, Alicia M Darnell, Montana F Reilly, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis ModelMaolin Yu, Mark W Ledeboer, Matthew Daniels, et al.
Cell Metabolism|March 26, 2019
Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are LimitingMark R Sullivan, Katherine R Mattaini, Emily A Dennstedt, et al.
Journal of the American Society of Nephrology : JASN|March 24, 2016
Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based CohortJulia Kozlitina, Haihong Zhou, Patricia N Brown, et al.
Medical Care|March 14, 2012
Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative dataBrian T Fisher, Tracey Harris, Kari Torp, et al.
Pediatric Blood & Cancer|April 10, 2026
Real-World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital-Dispensed ModelKatelyn Oranges, Kelly A Duffy, Sara McDonough, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 18, 2000
Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptideA S Dutta, M Crowther, J J Gormley, et al.
Pageof 32